S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
The perfect AI stock under $10 (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
66,000% upside on tiny biotech? (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
66,000% upside on tiny biotech? (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
The perfect AI stock under $10 (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
66,000% upside on tiny biotech? (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
66,000% upside on tiny biotech? (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
The perfect AI stock under $10 (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
66,000% upside on tiny biotech? (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
66,000% upside on tiny biotech? (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
The perfect AI stock under $10 (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
66,000% upside on tiny biotech? (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
66,000% upside on tiny biotech? (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture

Ligand Pharmaceuticals (LGND) Insider Trading & Ownership

$75.87
+2.31 (+3.14%)
(As of 02/23/2024 ET)

Ligand Pharmaceuticals (NASDAQ:LGND) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.40%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$237,520.00
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$1.35 M
Get LGND Insider Trade Alerts

Want to know when executives and insiders are buying or selling Ligand Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

LGND Insider Buying and Selling by Quarter


Ligand Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/22/2023Todd C DavisCEOBuy4,000$59.38$237,520.00  
5/16/2023John W KozarichDirectorSell4,444$77.20$343,076.80  
5/10/2023Stephen L SabbaDirectorSell6,408$77.13$494,249.04  
5/8/2023John W KozarichDirectorSell6,408$76.56$490,596.48  
3/24/2023Andrew ReardonInsiderSell300$69.92$20,976.00  
(Data available from 1/1/2013 forward)












LGND Insider Trading Activity - Frequently Asked Questions

Who is on Ligand Pharmaceuticals's Insider Roster?

The list of insiders at Ligand Pharmaceuticals includes Andrew Reardon, John L Higgins, John W Kozarich, Matthew W Foehr, Octavio Espinoza, Stephen L Sabba, and Todd C Davis. Learn more on insiders at LGND.

What percentage of Ligand Pharmaceuticals stock is owned by insiders?

10.40% of Ligand Pharmaceuticals stock is owned by insiders. Learn more on LGND's insider holdings.

Which Ligand Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased LGND shares in the last 24 months: Matthew W Foehr ($206,900.00), and Todd C Davis ($237,520.00).

How much insider buying is happening at Ligand Pharmaceuticals?

Insiders have purchased a total of 6,500 LGND shares in the last 24 months for a total of $444,420.00 bought.

Which Ligand Pharmaceuticals insiders have been selling company stock?

The following insiders have sold LGND shares in the last 24 months: Andrew Reardon ($20,976.00), John L Higgins ($1,581,900.00), John W Kozarich ($926,852.24), Octavio Espinoza ($128,285.44), and Stephen L Sabba ($494,249.04).

How much insider selling is happening at Ligand Pharmaceuticals?

Insiders have sold a total of 42,164 Ligand Pharmaceuticals shares in the last 24 months for a total of $3,152,262.72 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:LGND) was last updated on 2/25/2024 by MarketBeat.com Staff